News

Ocular Therapeutix (OCUL) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to a loss of $0.26 per share a year ago. These

Hillman Solutions Corp. (HLMN) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.16 per share a year ago

Astronics Corporation ATRO is slated to release third-quarter 2025 results on Nov. 4, after market close.The Zacks Consensus Estimate for revenues is pegged at $213.3 million, implying 4.7% growth

SM Energy Company SM reported third-quarter 2025 adjusted earnings of $1.33 per share, which surpassed the Zacks Consensus Estimate of $1.25. The bottom line, however, declined from the year-ago

Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $0.87 per share, missing the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.79 per share a

Verastem (VSTM) came out with a quarterly loss of $1.35 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to a loss of $0.6 per share a year ago. These figures are

Neuronetics (STIM) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.29 per share a year ago. These figures are

Wingstop (WING) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $0.88 per share a year ago. These figures

Dave Inc. (DAVE) came out with quarterly earnings of $4.24 per share, beating the Zacks Consensus Estimate of $2.29 per share. This compares to earnings of $1.51 per share a year ago. These figures

Solventum SOLV is scheduled to release third-quarter 2025 results on Nov. 6, after market close. In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 16.55%

Shares of Coinbase Global, Inc. (COIN) gained 4.6% on Oct. 31, following the company’s better-than-expected third-quarter 2025 results, backed by solid trading volume. However, the stock failed to

DENTSPLY SIRONA Inc. XRAY is scheduled to release third-quarter 2025 results on Nov. 6, before the opening bell.

In the last reported quarter, the company’s earnings beat the Zacks Consensus

Sunrun Inc. RUN is scheduled to release third-quarter 2025 results on Nov. 6, after market close. The company delivered an earnings surprise of 694.4% in the last reported quarter. Let’s discuss the

Gilead Sciences, Inc.’s GILD posted 3% year-over-year growth in total revenues for the third quarter of 2025.

Total revenues comprise product sales and royalty, contract and other revenues.

While

McKesson Corporation MCK is scheduled to report second-quarter fiscal 2026 results on Nov. 5, after market close.

The company delivered an earnings surprise of 0.36% in the last reported quarter

Moderna MRNA is set to report third-quarter 2025 earnings on Nov. 6, before the opening bell. The Zacks Consensus Estimate for sales and earnings is pegged at $860 million and a loss of $2.15 per

Chicago Atlantic Real Estate Finance, Inc. (REFI) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.56 per

Xometry (XMTR) came out with quarterly earnings of $0.11 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.02 per share a year ago. These figures are adjusted

Vital Farms (VITL) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.16 per share a year ago. These figures

Beam Therapeutics Inc. (BEAM) came out with a quarterly loss of $1.1 per share versus the Zacks Consensus Estimate of a loss of $0.98. This compares to a loss of $1.17 per share a year ago. These

Knife River (KNF) came out with quarterly earnings of $2.52 per share, beating the Zacks Consensus Estimate of $2.45 per share. This compares to earnings of $2.6 per share a year ago. These figures

Amicus Therapeutics (FOLD) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.1 per share a year ago. These

For Immediate Release

Chicago, IL – November 4, 2025 – Zacks Equity Research shares Banco Santander SAN as the Bull of the Day and Cogent Communications CCOI as the Bear of the Day. In addition

An updated edition of the Sept. 11, 2025 article.

Cyber threats are no longer occasional disruptions. Rather, they’ve become a constant business risk. From ransomware attacks to massive data

Clean Harbors, Inc. CLH reported dismal third-quarter 2025 results, wherein earnings and revenues missed the Zacks Consensus Estimate.

The stock price declined 15.2% since the company released